Cochlear Limited (ASX: COH)
Australia
· Delayed Price · Currency is AUD | Market Cap | 19.95B |
| Revenue (ttm) | 2.24B |
| Net Income (ttm) | 356.80M |
| Shares Out | 65.43M |
| EPS (ttm) | 5.43 |
| PE Ratio | 56.14 |
| Forward PE | 47.33 |
| Dividend | 4.20 (1.39%) |
| Ex-Dividend Date | Sep 17, 2024 |
| Volume | 114,230 |
| Open | 303.18 |
| Previous Close | 302.42 |
| Day's Range | 302.57 - 306.98 |
| 52-Week Range | 272.75 - 350.31 |
| Beta | 0.47 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 13, 2025 |
About Cochlear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia. [Read more]
Financial Performance
In 2024, Cochlear's revenue was 2.24 billion, an increase of 15.47% compared to the previous year's 1.94 billion. Earnings were 356.80 million, an increase of 18.70%.
Financial StatementsNews
MED-EL Corporation Announces FDA Approval of Expanded Candidacy Indications and Hearing Preservation Results for the MED-EL Cochlear Implant System
DURHAM, N.C.--(BUSINESS WIRE)-- #audiology--FDA approves expanded candidacy indications for MED-EL Cochlear Implant System.
Cochlear Limited goes ex dividend tomorrow
Healthy Aging Month | Daughter helps father win back his livelihood with cochlear implant
LONE TREE, Colo. , Sept. 16, 2024 /PRNewswire/ -- This healthy aging month, Cochlear, the global leader in implantable hearing solutions, is highlighting the Crosby family, who are a great example of ...
NMC to give ₹6L for each cochlear op
The Nagpur Municipal Corporation has introduced a scheme providing ₹6 lakh for cochlear implant surgeries for children aged 0-6, aiming to enhance their auditory abilities and improve communication sk...
Cochlear Non-GAAP EPS of $5.90, revenue of $2.26B beats by $630M; initiates FY25 guidance
Cochlear CEO: targeting 'around 10%' revenue growth per year
Dig Howitt, CEO and President of Cochlear, says that the company is focused on "raising awareness and referrals" to increase the market for hearing implants.
Cochlear CEO: targeting 'around 10%' revenue growth per year over the very long term
Dig Howitt, CEO and President of Cochlear, says that the company is focused on "raising awareness and referrals" to increase the market for hearing implants.
Cochlear Limited 2024 Q4 - Results - Earnings Call Presentation
Cochlear Limited (CHEOF) Q4 2024 Earnings Call Transcript
Cochlear profit up 19pc on strong sales growth
Cochlear says sales of its hearing implants globally will drive profit 6 to 11 per cent higher this year.
Cochlear shares slide after missing market expectations
Cochlear says sales of its hearing implants globally will drive profit higher by between 6 per cent and 11 per cent this year.
ASX 200 LIVE: ASX to rise, US CPI bolsters quarter-point rate cut
Australian shares are set to rise. All three US benchmarks higher. Reporting results: Telstra, Origin, Cochlear among others. Follow updates here.
U.S. Cochlear Implants Market Size, Share & Trends Analysis Report 2024-2030: Raising Awareness of the Benefits and Increasing Prevalence of Age-related Hearing Loss Bolsters Growth
Dublin, July 19, 2024 (GLOBE NEWSWIRE) -- The "U.S. Cochlear Implants Market Size, Share & Trends Analysis Report by Age Group (Adult, Pediatric), End-use (Hospitals, Clinics), Region, and Segment For...
Australia, Cochlear support Japan programme for child hearing implants
Hearing impaired children in Japan's coastal city of Shizuoka will from next year be able to listen, learn and speak better thanks to an A$6.5 million ($4.4 million) programme funded by the city and t...
Sensorion Announces Upcoming Presentation of Promising SENS-401 Results at the Next International Conference on Cochlear Implants and Other Implantable Technologies
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to res...
Sound Pharmaceuticals' IND Involving Cochlear Implantation Allowed by the FDA
SEATTLE & INNSBRUCK, Austria--(BUSINESS WIRE)--Sound Pharmaceuticals (SPI) is pleased to announce that it has received FDA notification that its Investigational New Drug Application (IND) may proceed ...
How the Victorian government almost killed the next Cochlear
The Seer Medical founders created a world first, wearable device which monitored brain activity to help treat 65 million people affected by epilepsy. Where did it all go so wrong?
20 Biggest Health Care Companies in Australia, 2024
CSL Limited led the Health Care Companies listed on the Australian Securities Exchange as of March 2024, with a market capitalization of over 135.02 billion Australian dollars. Meanwhile, Cochlear Lim...
Cochlear calls for action in Washington D.C. ahead of World Hearing Day
WASHINGTON , Feb. 28, 2024 /PRNewswire/ -- Today, Cochlear assembled a team of hearing experts to emphasize the importance of hearing health for policy makers at the Australian Embassy in Washington D...
Cochlear announces 2024 winners of annual scholarships
The Graeme Clark, Anders Tjellström and Vocational Scholarships recognize exemplary leaders throughout the hearing loss community LONE TREE, Colo. , Feb. 22, 2024 /PRNewswire/ -- Eight outstanding Co...
Cochlear Limited (CHEOF) Q2 2024 Earnings Call Transcript
Cochlear’s big first half delivers best dividend in a decade
ASX COH: Cochlear’s big first half reinforces upgraded full-year guidance
ASX 200: Shares to inch towards record; Westpac, Cochlear, Ampol to report
ASX to test record atop busy week with 80 companies reporting. Follow for more.
Cochlear Ltd Adverse Appeal Decision in the US Patent Infringement Case Conference Call Transcript
Cochlear Ltd Adverse Appeal Decision in the US Patent Infringement Case Conference Call Transcript
Cochlear Ltd Annual Shareholders Meeting Transcript
Cochlear Ltd Annual Shareholders Meeting Transcript